PharmaEssentia Wins FDA Approval for BESREMi in ET
BURLINGTON, Mass., August 31, 2026 PharmaEssentia announced that the U.S. Food and Drug Administration (FDA) has approved BESREMi® (ropeginterferon...
Hematology
Advertisement
Protagonist Therapeutics Wins FDA Approval for MIMRYLO
Protagonist Therapeutics, Newark, California, August 28, 2026 Protagonist Therapeutics announced that the U.S. Food and Drug Administration (FDA) has...
FDA Approves Janssen’s Imaavy for Rare Blood Disorder
SILVER SPRING, MARYLAND, Aug 26, 2026 The U.S. Food and Drug Administration (FDA) has approved Imaavy (nipocalimab-aahu) injection for...
Johnson & Johnson Wins FDA Approval for IMAAVY in wAIHA
Spring House, Pennsylvania, U.S. | August 24, 2026 Johnson & Johnson announced that the U.S. Food and Drug Administration...
Johnson & Johnson Expands TECVAYLI for Multiple Myeloma Care
Beerse, Belgium, August 21, 2026 Johnson & Johnson announced that the European Commission (EC) has approved an indication extension...
Advertisements
Damora Therapeutics Initiates Phase 1/1b Trial of DMR-001
WALTHAM, Massachusetts, August 5, 2026 Damora Therapeutics, Inc. announced the initiation of the global Phase 1/1b CLARITY-101 clinical trial...
Acarix Wins UAE Approval for AI-Powered CADScor System
United Arab Emirates, August 10, 2026 Acarix AB has announced that its CADScor® System, an artificial intelligence-enabled point-of-care diagnostic...
Nicox Files NCX 470 NDA in China Through Ocumension
Sophia Antipolis, France, August 10, 2026 Nicox SA announced that its exclusive Chinese licensee Ocumension Therapeutics has submitted a...
Innate Pharma to Advance Lacutamab Toward Phase 3 with Sobi
MARSEILLE, France, August 10, 2026 Innate Pharma SA announced plans to initiate the TELLOMAK-3 confirmatory Phase 3 study of...
Innovent and Daiichi Sankyo Partner on VANFLYTA in China
SAN FRANCISCO, USA and SUZHOU, China, August 9, 2026 Innovent Biologics and Daiichi Sankyo have entered into an exclusive...
Advertisement
